SCHEMBL31377484

SCHEMBL31377484

CCOC(=O)c1cc2c(NCc3ccc(OC)cc3)nc3cc(-c4cccnn4)ccc3n2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
THRB P10828 1/20 0.40
NPC1 O15118 2/20 0.38
NLRP3 Q96P20 1/20 0.38
TP53 P04637 5/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
KLKB1 P03952 2/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31377424 0.90 KLKB1 (0.46) MAPTTHRBNPC1NLRP3TP53
SCHEMBL31377529 0.87 NPSR1 (0.44) MAPTNPC1NLRP3TP53SMN1; SMN2
SCHEMBL31377473 0.84 MAPT (0.47) MAPTNPC1NLRP3TP53SMN1; SMN2
SCHEMBL31377542 0.84 MAPT (0.43) MAPTTHRBNPC1NLRP3TP53
SCHEMBL31377447 0.83 MAPT (0.46) MAPTNPC1NLRP3TP53SMN1; SMN2
SCHEMBL31377553 0.81 MAPT (0.42) MAPTNPC1NLRP3TP53SMN1; SMN2
SCHEMBL31377518 0.80 MEN1 (0.42) MAPTNPC1TP53GAAALDH1A1
SCHEMBL31377491 0.78 CD274 (0.38) MAPTTHRBNPC1NLRP3TP53
SCHEMBL31377534 0.77 MAPT (0.38) MAPTNPC1NLRP3ALDH1A1KDM4E
SCHEMBL31377471 0.69 NPC1 (0.54) MAPTNPC1TP53SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119219640-A Nitrogen-containing ternary condensed ring derivative and application thereof 杭州百新生物医药科技有限公司 2024-12-31 CN disclosed